Aromasin and Short-term memory loss - from FDA reports


Summary

Short-term memory loss is found among people who take Aromasin, especially for people who are female, 60+ old , have been taking the drug for 1 - 6 months, also take medication Zometa, and have Breast cancer . We study 7,554 people who have side effects while taking Aromasin from FDA. Among them, 198 have Short-term memory loss. Find out below who they are, when they have Short-term memory loss and more.

What to expect?

If you take Aromasin and have Short-term memory loss, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Aromasin and have Short-term memory loss

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Aromasin

Aromasin has active ingredients of exemestane. It is often used in breast cancer. (latest outcomes from Aromasin 7,764 users)

Short-term Memory Loss

Short-term memory loss has been reported by people with multiple sclerosis, depression, pain, high blood pressure, high blood cholesterol (latest reports from 105,191 Short-term memory loss patients).

On Feb, 21, 2017

7,554 people reported to have side effects when taking Aromasin.
Among them, 198 people (2.62%) have Short-term Memory Loss


Number of reports submitted per year:

Could Aromasin cause Short-term memory loss?

Time on Aromasin when people have Short-term Memory Loss *:

  • < 1 month: 7.14 %
  • 1 - 6 months: 71.43 %
  • 6 - 12 months: 21.43 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Short-term Memory Loss when taking Aromasin *:

  • female: 90.72 %
  • male: 9.28 %

Age of people who have Short-term Memory Loss when taking Aromasin *:

  • 0-1: 0.58 %
  • 2-9: 0.58 %
  • 10-19: 1.16 %
  • 20-29: 0.58 %
  • 30-39: 0.0 %
  • 40-49: 13.29 %
  • 50-59: 28.32 %
  • 60+: 55.49 %

Top conditions involved for these people *:

  • Breast Cancer (87 people, 43.94%)
  • Breast Cancer Metastatic (46 people, 23.23%)
  • Metastases To Bone (32 people, 16.16%)
  • Pain (22 people, 11.11%)
  • Hypercalcaemia (21 people, 10.61%)

Top co-used drugs for these people *:

  • Zometa (118 people, 59.60%)
  • Aredia (78 people, 39.39%)
  • Femara (68 people, 34.34%)
  • Faslodex (62 people, 31.31%)
  • Xanax (60 people, 30.30%)

Top other side effects for these people *:

  • Pain (122 people, 61.62%)
  • Stress And Anxiety (120 people, 60.61%)
  • Joint Pain (113 people, 57.07%)
  • Osteonecrosis Of Jaw (106 people, 53.54%)
  • Bone Disorder (99 people, 50.00%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Short-term memory loss when taking Aromasin?

Browse all side effects of Aromasin

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Short-term memory loss

Short-term memory loss

Could your condition cause Short-term memory loss

Short-term memory loss

Related studies

Can you answer these questions?

More questions for: Aromasin, Short-term memory loss

You may be interested in these reviews

More reviews for: Aromasin, Short-term memory loss